These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 18066780)
1. Synthesis of Leishmania cap-4 intermediates, cap-2 and cap-3. Lewdorowicz M; Stepinski J; Kierzek R; Jemielity J; Zuberek J; Yoffe Y; Shapira M; Stolarski R; Darzynkiewicz E Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1339-48. PubMed ID: 18066780 [TBL] [Abstract][Full Text] [Related]
2. Solid-supported synthesis of 5'-mRNA CAP-4 from Trypanosomatids. Lewdorowicz M; Jemielity J; Kierzek R; Shapira M; Stepinski J; Darzynkiewicz E Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1329-33. PubMed ID: 18066778 [TBL] [Abstract][Full Text] [Related]
3. Chemical synthesis and binding activity of the trypanosomatid cap-4 structure. Lewdorowicz M; Yoffe Y; Zuberek J; Jemielity J; Stepinski J; Kierzek R; Stolarski R; Shapira M; Darzynkiewicz E RNA; 2004 Sep; 10(9):1469-78. PubMed ID: 15273325 [TBL] [Abstract][Full Text] [Related]
4. Cap-binding activity of an eIF4E homolog from Leishmania. Yoffe Y; Zuberek J; Lewdorowicz M; Zeira Z; Keasar C; Orr-Dahan I; Jankowska-Anyszka M; Stepinski J; Darzynkiewicz E; Shapira M RNA; 2004 Nov; 10(11):1764-75. PubMed ID: 15388875 [TBL] [Abstract][Full Text] [Related]
5. Influence of electric charge variation at residues 209 and 159 on the interaction of eIF4E with the mRNA 5' terminus. Zuberek J; Jemielity J; Jablonowska A; Stepinski J; Dadlez M; Stolarski R; Darzynkiewicz E Biochemistry; 2004 May; 43(18):5370-9. PubMed ID: 15122903 [TBL] [Abstract][Full Text] [Related]
6. Binding specificities and potential roles of isoforms of eukaryotic initiation factor 4E in Leishmania. Yoffe Y; Zuberek J; Lerer A; Lewdorowicz M; Stepinski J; Altmann M; Darzynkiewicz E; Shapira M Eukaryot Cell; 2006 Dec; 5(12):1969-79. PubMed ID: 17041189 [TBL] [Abstract][Full Text] [Related]
7. Interaction between yeast eukaryotic initiation factor eIF4E and mRNA 5' cap analogues differs from that for murine eIF4E. Kiraga-Motoszko K; Stepinski J; Niedzwiecka A; Jemielity J; Wszelaka-Rylik M; Stolarski R; Zielenkiewicz W; Darzynkiewicz E Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1711-4. PubMed ID: 14565502 [TBL] [Abstract][Full Text] [Related]
8. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins. Niedzwiecka A; Marcotrigiano J; Stepinski J; Jankowska-Anyszka M; Wyslouch-Cieszynska A; Dadlez M; Gingras AC; Mak P; Darzynkiewicz E; Sonenberg N; Burley SK; Stolarski R J Mol Biol; 2002 Jun; 319(3):615-35. PubMed ID: 12054859 [TBL] [Abstract][Full Text] [Related]
9. Thermodynamic analysis of mRNA cap binding by the human initiation factor eIF4E via free energy perturbations. Guimarães CR; Kopecky DJ; Mihalic J; Shen S; Jeffries S; Thibault ST; Chen X; Walker N; Cardozo M J Am Chem Soc; 2009 Dec; 131(50):18139-46. PubMed ID: 19924990 [TBL] [Abstract][Full Text] [Related]
10. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation. Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299 [TBL] [Abstract][Full Text] [Related]
11. Phosphorothioate analogs of m7GTP are enzymatically stable inhibitors of cap-dependent translation. Kowalska J; Lukaszewicz M; Zuberek J; Ziemniak M; Darzynkiewicz E; Jemielity J Bioorg Med Chem Lett; 2009 Apr; 19(7):1921-5. PubMed ID: 19269171 [TBL] [Abstract][Full Text] [Related]
12. Biophysical approach to studies of cap-eIF4E interaction by synthetic cap analogs. Niedzwiecka A; Stepinski J; Antosiewicz JM; Darzynkiewicz E; Stolarski R Methods Enzymol; 2007; 430():209-45. PubMed ID: 17913640 [TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate mRNA cap analog attached to Sepharose for affinity chromatography of decapping enzymes. Szczepaniak SA; Jemielity J; Zuberek J; Kufel J; Darzynkiewicz E Nucleic Acids Symp Ser (Oxf); 2008; (52):295-6. PubMed ID: 18776370 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biochemical studies of tetraphosphate 5' mRNA cap analogs bearing bisphosphonate modification. Rydzik A; Zuberek J; Kowalska J; Lukaszewicz M; Darzynkiewicz E; Jemielity J Nucleic Acids Symp Ser (Oxf); 2008; (52):287-8. PubMed ID: 18776366 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability. Grudzien-Nogalska E; Stepinski J; Jemielity J; Zuberek J; Stolarski R; Rhoads RE; Darzynkiewicz E Methods Enzymol; 2007; 431():203-27. PubMed ID: 17923237 [TBL] [Abstract][Full Text] [Related]
17. m7GTP alphaS is a strong and stable inhibitor of cap-dependent translation. Kowalska J; Lukaszewicz M; Zuberek J; Ziemniak M; Strenkowska M; Darzynkiewicz E; Jemielity J Nucleic Acids Symp Ser (Oxf); 2008; (52):291-2. PubMed ID: 18776368 [TBL] [Abstract][Full Text] [Related]
18. Thermodynamics of mRNA 5' cap binding by eukaryotic translation initiation factor eIF4E. Niedzwiecka A; Darzynkiewicz E; Stolarski R Biochemistry; 2004 Oct; 43(42):13305-17. PubMed ID: 15491137 [TBL] [Abstract][Full Text] [Related]
19. Nutritional stress affects an atypical cap-binding protein in Leishmania. Zinoviev A; Manor S; Shapira M RNA Biol; 2012 Dec; 9(12):1450-60. PubMed ID: 23135001 [TBL] [Abstract][Full Text] [Related]
20. The first examples of mRNA cap analogs bearing boranophosphate modification. Kowalska J; Zuberek J; Darzynkiewicz ZM; Lukaszewicz M; Darzynkiewicz E; Jemielity J Nucleic Acids Symp Ser (Oxf); 2008; (52):289-90. PubMed ID: 18776367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]